Lallemand Health Solutions announced that its ProbioKid probiotic formula is now Generally Recognized as Safe (GRAS) in the United States and Canada.
Photo © iStockphoto.com/shironosov
Lallemand Health Solutions (Montreal) announced that its ProbioKid probiotic formula for young children is now recognized as safe in both the United States and Canada. In the United States, ProbioKid is now Generally Recognized as Safe (GRAS) for infants and children in food and beverage products, including infant formula. Meanwhile, in Canada, Health Canada has extended a previously approved immune-health claim for ProbioKid under Natural Products Number 800199993. The claim, which states “Helps to reinforce the body’s natural defenses in children,” had applied to infants over the age of six months but has now also been approved for infants over the age of three months. Lallemand says this expanded approval is the result of additional safety studies conducted by the company. ProbioKid comprises three of Lallemand’s proprietary probiotic strains: Lactobacillus helveticus Rosell-52, for balancing microbiota and helping to prevent intestinal infections; Bifidobacterium infantis Rosell-33; and Bifidobacterium bifidum Rosell-71, which helps modulate non-specific immune diseases. Solange Henoud, Lallemand’s regulatory affairs director, commented in a press release: “Not only are these achievements…key for the North American markets but they also can be seen as a global recognition of our strains safety in babies, being a vulnerable population. In their opinion report, the scientific experts mentioned that ‘other qualified and competent scientists reviewing the same publicly available information would reach the same conclusion.’” According to a press release, Lallemand’s ProbioKid probiotic formula has been available on the market around the world for 15 years under different names and is popular in countries such as China. Also read: Probiotoc BLIS K12 Defends Against Variety of Oral Infections In Children, Study Suggests 2016 Probiotic Research Update
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.
Recent study compares the effectiveness of two probiotic products on colicky infants
October 31st 2024The study compared AB-Biotics and Kaneka Probiotics’ probiotic formulation of Bifidobacterium longum KABP®-042 and Pediococcus pentosaceus KABP®-041 to Lactobacillus reuteri DSM17938 (LR) from Biogaia.